Literature DB >> 5423198

Drug-induced agranulocytosis, with special reference to aminophenazone. I. Adults.

I P Palva, O O Mustala.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5423198     DOI: 10.1111/j.0954-6820.1970.tb02916.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  10 in total

1.  Carcinogenic N-nitro-dimethylamine from the reaction of the analgesic amidopyrine and nitrite extracted from foodstuffs.

Authors:  J LaBar; J Sander
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1975-11-25

2.  The etiology and management of leukopenia.

Authors:  V W Ing
Journal:  Can Fam Physician       Date:  1984-09       Impact factor: 3.275

3.  [Aminophenazone as cause of allergic reactions (author's transl)].

Authors:  G Sorgo
Journal:  Arch Toxicol       Date:  1974       Impact factor: 5.153

Review 4.  Drug-induced agranulocytosis.

Authors:  H Heimpel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

5.  Agranulocytosis associated with dipyrone (metamizol).

Authors:  Luisa Ibáñez; Xavier Vidal; Elena Ballarín; Joan-Ramon Laporte
Journal:  Eur J Clin Pharmacol       Date:  2004-12-03       Impact factor: 2.953

6.  Assessment of the (14C) aminopyrine breath test in liver disease.

Authors:  J Galizzi; R G Long; B H Billing; S Sherlock
Journal:  Gut       Date:  1978-01       Impact factor: 23.059

Review 7.  Haematological effects of non-narcotic analgesics.

Authors:  P A Miescher; W Pola
Journal:  Drugs       Date:  1986       Impact factor: 9.546

8.  The design of a study of the drug etiology of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study.

Authors: 
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Breath 14CO2 after intravenous administration of [14C]aminopyrine in liver diseases.

Authors:  S Pauwels; A P Geubel; C Dive; C Beckers
Journal:  Dig Dis Sci       Date:  1982-01       Impact factor: 3.199

10.  Agranulocytosis during treatment with chlozapine.

Authors:  J Idänpään-Heikkilä; E Alhava; M Olkinuora; I P Palva
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.